Economists and institutions have cut their forecasts and experts are predicting the potential onset of recessionary environments.

Global companies are also concerned about the rising risk of Covid-19, with thousands of the world’s leading companies explicitly mentioning its impact on their business in their latest company filings.


The IMF predicts global growth will decline by 4.9% in 2020, down 1.9% from its April forecast.


Global economic output will fall by $8.5tn over next two years, according to the United Nations World Economic Situation and Prospects.

Impact of Covid-19 on asset prices


As of 01 July 2020

In Vitro Diagnostic Devices

In the US, routine testing, which includes testing for cholesterol, glucose levels, complete blood count, and hemoglobin, was reported to be down between 40% - 55% by leading commercial diagnostic labs Quest Diagnostics and LabCorp during the first quarter of 2020.


GlobalData estimates that 2020 hip reconstruction revenue in the 5EU will decline by over 15%, to around $1bn, and by 12% in the US. 

General Surgery Devices


In the US, 29 states have allowed the resumption of general surgeries but under strict guidelines to prevent further Covid-19 infection. 

Key mediCal market developments

Share this article